Skip to main content

Medical Subject Headings

Search from vocabulary

Content language

Concept information

... > Organic Chemicals > Hydrocarbons > Hydrocarbons, Cyclic > Hydrocarbons, Aromatic > Polycyclic Aromatic Hydrocarbons > Phenanthrenes > Morphinans > Naloxone > Naltrexone
... > Polycyclic Compounds > Polycyclic Aromatic Hydrocarbons > Phenanthrenes > Morphinans > Naloxone > Naltrexone
... > Heterocyclic Compounds > Heterocyclic Compounds, Fused-Ring > Heterocyclic Compounds, 4 or More Rings > Morphinans > Naloxone > Naltrexone
... > Heterocyclic Compounds > Alkaloids > Opiate Alkaloids > Morphinans > Naloxone > Naltrexone
Heterocyclic Compounds > Heterocyclic Compounds, Bridged-Ring > Morphinans > Naloxone > Naltrexone

Preferred term

Naltrexone  

Type

  • Topical Descriptor

Broader concept

Entry terms

  • Antaxone
  • Celupan
  • EN 1639A
  • EN-1639A
  • EN1639A
  • Naltrexone Hydrochloride
  • ReVia
  • Trexan

Scope note

  • Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.

History note

  • 1986 (1976)

In other languages

URI

http://www.yso.fi/onto/mesh/D009271

Download this concept:

RDF/XML TURTLE JSON-LD Created 7/23/75, last modified 4/10/18